UNICA IRIS Institutional Research Information System

PANI, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 85.600
NA - Nord America 5.898
AS - Asia 2.686
SA - Sud America 1.101
AF - Africa 94
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 95.392
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 84.300
US - Stati Uniti d'America 5.790
SG - Singapore 1.131
BR - Brasile 899
CN - Cina 821
SE - Svezia 452
VN - Vietnam 342
DE - Germania 212
UA - Ucraina 123
GB - Regno Unito 115
FI - Finlandia 103
AR - Argentina 92
FR - Francia 85
KR - Corea 65
AT - Austria 60
HK - Hong Kong 55
CA - Canada 49
BD - Bangladesh 48
ID - Indonesia 41
MX - Messico 39
MA - Marocco 38
NL - Olanda 37
IN - India 34
EC - Ecuador 33
ZA - Sudafrica 24
IQ - Iraq 19
PL - Polonia 19
RU - Federazione Russa 19
CO - Colombia 18
TR - Turchia 18
PK - Pakistan 15
PY - Paraguay 14
CL - Cile 12
ES - Italia 12
VE - Venezuela 12
JP - Giappone 11
EG - Egitto 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
PE - Perù 9
AU - Australia 8
IR - Iran 8
UY - Uruguay 8
JO - Giordania 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
BG - Bulgaria 6
DK - Danimarca 6
IE - Irlanda 6
PT - Portogallo 6
AZ - Azerbaigian 5
DZ - Algeria 5
LT - Lituania 5
AL - Albania 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SO - Somalia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BJ - Benin 1
BY - Bielorussia 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
Totale 95.384
Salva come PNG Salva come JPEG
Città #
Cagliari 80.398
Uta 3.310
Fairfield 727
Dallas 624
Ashburn 574
Singapore 450
Boardman 357
Nyköping 335
Woodbridge 328
Seattle 296
Houston 288
Cambridge 264
Wilmington 242
Chandler 184
Beijing 159
Ann Arbor 146
Ho Chi Minh City 127
Santa Clara 121
Los Angeles 105
Jacksonville 94
Dearborn 92
Shanghai 87
Hefei 81
Boston 77
Helsinki 75
Buffalo 73
Rome 73
New York 72
São Paulo 71
Nanjing 66
Dong Ket 64
Seoul 63
Hong Kong 53
Munich 49
San Diego 48
Hanoi 39
Milan 38
Nuremberg 37
The Dalles 33
Chicago 31
London 29
Rio de Janeiro 28
Belo Horizonte 27
Vienna 26
Casablanca 25
Frankfurt am Main 24
Hebei 22
Jiaxing 22
Redwood City 22
Brasília 21
Nanchang 21
Phoenix 21
Redondo Beach 21
Montreal 19
Bologna 18
Sèlegas 18
Guangzhou 17
Toronto 17
Johannesburg 16
Changsha 15
Curitiba 14
Lappeenranta 14
Guayaquil 13
Norwalk 13
Sassari 13
Warsaw 13
Atlanta 12
Brooklyn 12
Buenos Aires 12
Mountain View 11
Naples 11
Shenyang 11
Tianjin 11
Bari 10
Biên Hòa 10
Catania 10
Guarulhos 10
Haiphong 10
Mexico City 10
Redmond 10
Asunción 9
Council Bluffs 9
Da Nang 9
Düsseldorf 9
Jinan 9
Paris 9
Quito 9
San Mateo 9
Stockholm 9
Tampa 9
Turin 9
Washington 9
Brussels 8
Chennai 8
Goiânia 8
Lauterbourg 8
Salt Lake City 8
San Francisco 8
Selargius 8
Sumaré 8
Totale 91.182
Salva come PNG Salva come JPEG
Nome #
Overexpression of the cytokine BAFF and autoimmunity risk 4.054
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.720
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.655
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.944
Long-term lithium and estimated glomerular filtration rate 2.877
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.865
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.075
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 1.958
Risk of adverse pregnancy outcomes in women with CKD 1.572
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population 1.532
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 1.498
Cardiorenal syndrome type 4 (CRS 4) associated with anaemia long term survival analysis 1.446
Exercise-Associated hyponatremia: 2017 update 1.444
Genome-Wide Analysis Studies and Chronic Kidney Disease 1.403
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 1.399
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis 1.314
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up 1.293
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? 1.221
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 1.163
Opening an onconephrology clinic: recommendations and basic requirements 1.142
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group 1.139
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results 1.137
A multicenter study of the predictive value of crescents in IgA nephropathy 1.112
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 1.108
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment 1.097
Treatment of primary membranous nephropathy: where are we now? 1.096
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) 1.069
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 1.019
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama 1.007
Diabetic kidney disease: A syndrome rather than a single disease 988
Patient Selection and Timing of Continuous Renal Replacement Therapy 969
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group 943
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 931
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population 890
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations 882
Glomerular diseases and cancer: evaluation of underlying malignancy 833
FSGS: from pathogenesis to the histological lesion 817
Diagnosis of complement alternative pathway disorders 805
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy 785
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy 767
Sodium and Volume Disorders in Advanced Chronic Kidney Disease 751
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort 731
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 720
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study 689
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity 682
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 661
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 655
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 642
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries 638
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside 636
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy 625
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 604
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 593
Hyperkalemia in hemodialysis patients 585
Standard immunosuppressive therapy of immune-mediated glomerular diseases 567
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report 561
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 551
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 548
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy 537
Chronic kidney disease of undetermined etiology around the world 535
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 513
Tossicità renale da farmaci antineoplastici 508
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 505
Immunosuppressive treatment in dialysis patients 494
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study 477
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario 473
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine 467
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry 460
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial 454
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy 451
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 440
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome 428
DIAGNOSIS AND PREVALENCE OF NON DIABETIC RENAL DISEASES IN PATIENTS WITH DIABETES: A TWENTY YEARS EXPERIENCE 418
La Nefrologia in Tasca 415
Classification and Management of MGRS Related Diseases 410
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome 399
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 389
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 385
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE 382
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 382
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients 381
Transplant Candidate with Cancer: Should We Proceed? 375
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis 373
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 367
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 363
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 363
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 358
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS 348
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 344
[A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)]. 338
The role of rituximab in the treatment of ANCA-associated systemic vasculitis 331
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009 328
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 327
L'utilita' delle biopsie protocollari nel trapianto di rene: pro e contro.[The usefulness of protocol biopsies after kidney transplant: pros and cons] 323
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium 322
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study 318
An Integrated Multidisciplinary Approach to the Care of Renal Cancer Patients Undergoing Nephrectomy 318
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 314
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification 306
Is renal vasculitis in patients with systemic lupus erythematosus a bad prognostic factor? 301
Totale 88.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.125
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.054 0 0 0 0 0 2.199 1.742 1.235 391 979 853 655
2021/20226.217 720 494 245 360 463 549 326 238 408 484 1.036 894
2022/20238.620 796 854 908 604 876 838 473 742 613 564 916 436
2023/202412.187 403 413 448 630 1.134 2.215 2.376 814 645 613 1.121 1.375
2024/202522.698 3.917 5.284 3.102 3.253 1.643 2.578 1.495 136 334 371 267 318
2025/20264.168 637 349 1.288 1.056 780 58 0 0 0 0 0 0
Totale 95.855